Contribution: Industrial Research Assistance Program – Contributions to Firms
Rakovina Therapeutics Inc.
$56,803.00
Lead optimization of anti-cancer agents
FY 2021-22 · 2021-10-11
Summary
Lead optimization of a novel class of small molecule anti-cancer agents through evaluation of their pharmacokinetic profiles and ability to penetrate the blood brain barrier.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Vancouver|Vancouver, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
795712470
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2021-10-11 | 2021-22 | $56,803.00 |
| 1 | 2021-10-11 | 2021-22 | $56,803.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 107 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 107 jours.
Agreement End Date
2022-06-30
Agreement Number
980818
Agreement Start Date
2021-10-11
Agreement Title
Lead optimization of anti-cancer agents
Agreement Title (French)
Optimiser des agents anticancéreux
Agreement Type
Contribution
Agreement Value
$56,803.00
Amendment Date
2022-03-01
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Lead optimization of a novel class of small molecule anti-cancer agents through evaluation of their pharmacokinetic profiles and ability to penetrate the blood brain barrier.
Description (French)
Optimiser une nouvelle classe de petites molécules anticancéreuses en évaluant leur profil pharmacocinétique et leur capacité à pénétrer la barrière hémato-encéphalique.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vancouver Centre
Federal Riding (French)
Vancouver-Centre
Federal Riding Number
59034
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
795712470
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
Rakovina Therapeutics Inc.
Recipient Postal Code
V6B 0A5
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2021-2022-Q3-980818
